KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hims & Hers Health (HIMS) Assets (2019 - 2025)

Hims & Hers Health (HIMS) has disclosed Assets for 7 consecutive years, with $2.2 billion as the latest value for Q4 2025.

  • Quarterly Assets rose 204.54% to $2.2 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.2 billion through Dec 2025, up 204.54% year-over-year, with the annual reading at $2.2 billion for FY2025, 204.54% up from the prior year.
  • Assets hit $2.2 billion in Q4 2025 for Hims & Hers Health, down from $2.2 billion in the prior quarter.
  • In the past five years, Assets ranged from a high of $2.2 billion in Q3 2025 to a low of $345.9 million in Q1 2021.
  • Historically, Assets has averaged $703.1 million across 5 years, with a median of $420.3 million in 2021.
  • Biggest five-year swings in Assets: dropped 12.9% in 2022 and later surged 290.76% in 2025.
  • Year by year, Assets stood at $420.6 million in 2021, then fell by 12.9% to $366.3 million in 2022, then increased by 20.43% to $441.2 million in 2023, then surged by 60.37% to $707.5 million in 2024, then soared by 204.54% to $2.2 billion in 2025.
  • Business Quant data shows Assets for HIMS at $2.2 billion in Q4 2025, $2.2 billion in Q3 2025, and $1.9 billion in Q2 2025.